Monoclonal Mouse anti‑Human ICAM2 / CD102 Antibody (clone B‑T1, IF, WB) LS‑C43308
Monoclonal Mouse anti‑Human ICAM2 / CD102 Antibody (clone B‑T1, IF, WB) LS‑C43308
Note: This antibody replaces LS-C57207
Antibody:
ICAM2 / CD102 Mouse anti-Human Monoclonal (B-T1) Antibody
Application:
IF, WB, IP, Flo
Format:
Unconjugated, Unmodified
Overview
Antibody:
ICAM2 / CD102 Mouse anti-Human Monoclonal (B-T1) Antibody
Application:
IF, WB, IP, Flo
Format:
Unconjugated, Unmodified
Specifications
Description
CD102 antibody LS-C43308 is an unconjugated mouse monoclonal antibody to human CD102 (ICAM2). Validated for Flow, IF, IP and WB.
Target
Human ICAM2 / CD102
Synonyms
ICAM2 | CD102 | ICAM-2 | CD102 antigen
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG1
Monoclonal
Conjugations
Unconjugated
Purification
Ion exchange chromatography
Immunogen
ICAM-2 transfected CHO cells.
Specificity
Recognizes human Intercellular adhesion molecule 2, also known as CD102 or ICAM-2. CD102 is a 275 amino acid ~55-65 kD single pass type-1 transmembrane glycoprotein containing two domains. Inhibits cell adhesion and T cell activation and also recognizes soluble ICAM-2.
Applications
- Immunofluorescence
- Western blot
- Immunoprecipitation
- Flow Cytometry (1:20 - 1:50)
Usage
Flow Cytometry: Use 10 ul of the suggested working dilution to label 10^6 cells in 100 ul. Method sheets are available on request.
Presentation
PBS, 0.09% Sodium Azide
Storage
Store at 4°C or at -20°C. Store undiluted. Avoid freeze-thaw cycles. Microcentrifugation recommended if solution contains precipitate.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot
Reactivity:
Human
Range:
312-20000 pg/ml
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 2/12/2025